On ECHEMI
Home > Drugs > Ji Lin Jin Sheng Pharmaceutical Co., Ltd.
Ji Lin Jin Sheng Pharmaceutical Co., Ltd.
  • Founded in:

    2014-01-26
  • Country:

    China China
  • Address:

    No. 1688, Wutong Road, Meihekou City, Jilin Province
  • Tax NO.:

    91220581088830315W
  • Registered Funds:

    19.5 million yuan
  • Email:

Related Drugs
Clindamycin Hydrochloride for Injection
Clindamycin hydrochloride.
Name Description Content CAS NO. Registered Holders
Clindamycin hydrochloride

Extract from the above information

More

Extract from the above information

21462-39-5 34
Potassium Magnesium Aspartate for Injection
This product is a compound preparation, and its components are: each 1 ml contains 79-91 mg of aspartic acid, 10.6-12.2 mg of potassium, and 3.9-4.5 mg of magnesium.
Name Description Content CAS NO. Registered Holders
L-ASPARTIC ACID

As the precursor of oxaloacetate in the body, it plays an important role in the tricarboxylic acid cycle and participates in the ornithine cycle, combining ammonia and carbon dioxide to form urea. It has a strong affinity for cells and can be used as a carrier of potassium and magnesium ions to help them enter cells, increase the concentration of potassium and magnesium in cells, accelerate the tricarboxylic acid cycle of liver cells, and have a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

More

As the precursor of oxaloacetate in the body, it plays an important role in the tricarboxylic acid cycle and participates in the ornithine cycle, combining ammonia and carbon dioxide to form urea. It has a strong affinity for cells and can be used as a carrier of potassium and magnesium ions to help them enter cells, increase the concentration of potassium and magnesium in cells, accelerate the tricarboxylic acid cycle of liver cells, and have a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

79-91mg 6899-03-2 18
Potassium

As a carrier of potassium ions, it helps them enter cells, increases the concentration of potassium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

More

As a carrier of potassium ions, it helps them enter cells, increases the concentration of potassium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

10.6-12.2mg 0
Magnesium

As a carrier of magnesium ions, it helps them enter cells, increases the concentration of magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

More

As a carrier of magnesium ions, it helps them enter cells, increases the concentration of magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

3.9-4.5mg 0
Potassium Magnesium Aspartate for Injection
This product is a compound preparation, and its components are: each 1 ml contains 79-91 mg of aspartic acid, 10.6-12.2 mg of potassium, and 3.9-4.5 mg of magnesium.
Name Description Content CAS NO. Registered Holders
L-ASPARTIC ACID

As the precursor of oxaloacetate in the body, it plays an important role in the tricarboxylic acid cycle and participates in the ornithine cycle, combining ammonia and carbon dioxide to form urea. It has a strong affinity for cells and can be used as a carrier of potassium and magnesium ions to help them enter cells, increase the concentration of potassium and magnesium in cells, accelerate the tricarboxylic acid cycle of liver cells, and have a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

More

As the precursor of oxaloacetate in the body, it plays an important role in the tricarboxylic acid cycle and participates in the ornithine cycle, combining ammonia and carbon dioxide to form urea. It has a strong affinity for cells and can be used as a carrier of potassium and magnesium ions to help them enter cells, increase the concentration of potassium and magnesium in cells, accelerate the tricarboxylic acid cycle of liver cells, and have a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

79-91mg 6899-03-2 18
Potassium

As an ion carrier, it enters cells, increases the concentration of potassium and magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

More

As an ion carrier, it enters cells, increases the concentration of potassium and magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

10.6-12.2mg 0
Magnesium

As an ion carrier, it enters cells, increases the concentration of potassium and magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

More

As an ion carrier, it enters cells, increases the concentration of potassium and magnesium in cells, accelerates the tricarboxylic acid cycle of liver cells, and has a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

3.9-4.5mg 0
Isosorbide dinitrate for injection
The main ingredient of this product is isosorbide dinitrate
Name Description Content CAS NO. Registered Holders
Isosorbide dinitrate

Directly relaxes smooth muscle, especially vascular smooth muscle; the dilation effect on post-capillary veins is more persistent than that on arteries. It has no obvious direct effect on the myocardium. Due to the dilation of capacitance vessels, the venous return to the heart is reduced, reducing the preload of the heart. At the same time, the peripheral resistance vessels expand, blood pressure drops, the left ventricular ejection resistance is reduced, and the afterload of the heart is reduced. The reduction of the preload and afterload of the heart reduces the oxygen consumption of the myocardium.

More

Directly relaxes smooth muscle, especially vascular smooth muscle; the dilation effect on post-capillary veins is more persistent than that on arteries. It has no obvious direct effect on the myocardium. Due to the dilation of capacitance vessels, the venous return to the heart is reduced, reducing the preload of the heart. At the same time, the peripheral resistance vessels expand, blood pressure drops, the left ventricular ejection resistance is reduced, and the afterload of the heart is reduced. The reduction of the preload and afterload of the heart reduces the oxygen consumption of the myocardium.

87-33-2 23
Isosorbide dinitrate for injection
The main ingredient of this product is isosorbide dinitrate
Name Description Content CAS NO. Registered Holders
Isosorbide dinitrate

Directly relaxes smooth muscle, especially vascular smooth muscle; the dilation effect on post-capillary veins is more persistent than that on arteries. It has no obvious direct effect on the myocardium. Due to the dilation of capacitance vessels, the venous return to the heart is reduced, reducing the preload of the heart. At the same time, the peripheral resistance vessels expand, blood pressure drops, the left ventricular ejection resistance is reduced, and the afterload of the heart is reduced. The reduction of the preload and afterload of the heart reduces the oxygen consumption of the myocardium.

More

Directly relaxes smooth muscle, especially vascular smooth muscle; the dilation effect on post-capillary veins is more persistent than that on arteries. It has no obvious direct effect on the myocardium. Due to the dilation of capacitance vessels, the venous return to the heart is reduced, reducing the preload of the heart. At the same time, the peripheral resistance vessels expand, blood pressure drops, the left ventricular ejection resistance is reduced, and the afterload of the heart is reduced. The reduction of the preload and afterload of the heart reduces the oxygen consumption of the myocardium.

87-33-2 23
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.